KLOW Stack (GHK-Cu + BPC-157 + TB-500 + KPV)
The KLOW stack combines GHK-Cu, BPC-157, TB-500, and KPV for skin rejuvenation, tissue repair, and anti-inflammatory support. It is best understood as an expanded Glow stack with an added inflammation-focused layer.
KLOW Stack Quick Overview
| Peptide | Purpose | Typical Dose |
|---|---|---|
| GHK-Cu | Collagen, skin remodeling | 2–4 mg weekly |
| BPC-157 | Local tissue repair | 250–500 mcg daily |
| TB-500 | Systemic healing | 2–5 mg weekly |
| KPV | Anti-inflammatory support | 500 mcg daily |
What Is the KLOW Stack
The KLOW stack layers the Glow stack foundation with KPV. GHK-Cu is commonly discussed for collagen support and skin remodeling, BPC-157 for localized tissue repair, and TB-500 for broader systemic healing. KPV is a tripeptide often discussed for anti-inflammatory and barrier-supportive applications.
In practical terms, KLOW is used when someone wants the cosmetic and tissue-repair focus of Glow but with additional redness, inflammation, or irritation support layered in. Evidence for the exact stack is limited; most protocols are assembled from individual peptide literature and community practice.
How the Stack Works
GHK-Cu
- Collagen & elastin — supports remodeling of skin structure and extracellular matrix
- Skin regeneration — is commonly discussed for firmness, texture, and cosmetic recovery
- Copper signaling — interacts with pathways tied to wound repair and tissue turnover
BPC-157
- Angiogenesis — may support blood vessel formation around stressed tissue
- Tendon repair — is often discussed for soft-tissue and connective-tissue support
- Localized use — frequently paired with targeted recovery goals
TB-500
- Cell migration — supports repair-cell movement and tissue remodeling
- Systemic healing — is often discussed for broad recovery rather than one local site
- Mobility support — commonly paired with injury-recovery protocols
KPV
- Inflammation control — is studied for downregulating inflammatory signaling
- Barrier support — is commonly discussed for gut and skin irritation contexts
- Redness support — may complement cosmetic stacks focused on calmer skin
Together, KLOW combines collagen support, local repair, systemic healing, and inflammation control. That makes it a differentiated option from Glow when the goal includes both cosmetic recovery and calmer skin or tissue responses.
Benefits
- Skin rejuvenation and collagen support
- Improved skin firmness and elasticity
- Scar and wound remodeling
- Reduced inflammation and redness support
- Support for tendon, ligament, and joint recovery
- Broader recovery coverage than Glow alone
Typical Protocol
| Week | GHK-Cu | BPC-157 | TB-500 | KPV |
|---|---|---|---|---|
| 1–6 | 2–4 mg weekly | 250–500 mcg daily | 2–5 mg weekly | 500 mcg daily |
| 7–8 | Optional maintenance | Optional maintenance | Optional maintenance | Optional maintenance |
Cycle 6–8 weeks on, then 4 weeks off. See GHK-Cu guide, BPC-157 protocol, and TB-500 protocol for more context on the individual components.
Results Timeline
- Week 1–2: Early texture, redness, or inflammation changes may show first
- Week 3–4: Users often look for firmer skin and better tissue recovery
- Week 5–8: Collagen remodeling and broader repair effects are typically the longer-range goal
Timelines vary by tissue type, protocol, and baseline condition. For individual peptide context, see the GHK-Cu results timeline and BPC-157 timeline guide.
Stack Calculator
FAQs
What is the KLOW stack?
The KLOW stack combines GHK-Cu, BPC-157, TB-500, and KPV for skin support, tissue repair, and anti-inflammatory recovery. It builds on the Glow stack by adding KPV for additional inflammation-focused support.
How is KLOW different from the Glow stack?
KLOW includes all Glow stack components, then adds KPV. That extra peptide is commonly used for inflammation, redness, and immune-modulating support, making KLOW a broader recovery-oriented beauty stack.
How long should a KLOW cycle run?
A common pattern is 6–8 weeks on followed by a 4-week break. Individual protocols vary by goals, tolerance, and product quality.
Can the KLOW stack be used for skin and tissue recovery together?
Yes. The stack is commonly discussed for combined skin, connective-tissue, and recovery goals because it layers collagen-supportive, tissue-repair, and anti-inflammatory peptides in one protocol.
Is the KLOW stack supported by human data?
Human data for the exact four-peptide combination is limited. Most discussion of KLOW is extrapolated from preclinical research and individual peptide literature rather than controlled trials on the full stack.
Sources
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data (PubMed)
- Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth (PubMed)
- The actin binding site on thymosin beta4 promotes angiogenesis (PubMed)
- The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients (PubMed)
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation (PubMed)
Internal linking
Related Protocols
Related Calculators
Related Stacks
For educational and research purposes only. Not medical advice. Consult a licensed healthcare professional for personal guidance.